Amphotericin B lipid complex compared with amphotericin B in the treatment of cryptococcal meningitis in patients with AIDS

Clinical Infectious Diseases

Volumn 22, Issue 2, 1996, Pages 315-321

  Sharkey, Patricia K ^a   Graybill, John R ^b   Johnson, Edward S ^b   Hausrath, Stephen G ^b   Pollard, Richard B ^b   Kolokathis, Antonia ^b   Mildvan, Donna ^b   Fan Havard, Patty ^b   Eng, Robert H K ^b   Patterson, Thomas F ^b   Pottage Jr , John C ^b   Simberkoff, Michael S ^b   Wolf, Judith ^b   Meyer, Richard D ^b   Gupta, Renu ^b   Lee, Lily W ^b   Gordon, David S ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BLOOD TOXICITY; CHILL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CRYPTOCOCCUS NEOFORMANS; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; FUNGAL MENINGITIS; HEADACHE; HEMOGLOBIN DETERMINATION; HUMAN; INSOMNIA; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; NAUSEA; NEPHROTOXICITY; PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; RIGOR; VOMITING;

EID: 9044250097     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/22.2.315     Document Type: Article

References (14)

1. Janoff AS, Boni LT, Popescu MC, et al. Unusual lipid structures selectively reduce the toxicity of amphotericin B. Proc Natl Acad Sci USA 1988;85:6122-6.
2. Perkins WR, Minchey SR, Boni LT, et al. Amphotericin B-phospholipid interactions responsible for reduced mammalian cell toxicity. Biochim Biophys Acta 1992;1107:271-82.
3. Clark JM, Whitney RR, Olsen SJ, et al. Amphotericin B lipid complex therapy of experimental fungal infections in mice. Antimicrob Agents Chemother 1991;35:615-21.
4. Clemons KV, Stevens DA. Comparative efficacies of amphotericin B lipid complex and amphotericin B deoxycholate suspension against murine blastomycosis. Antimicrob Agents Chemother 1991;35:2144-6.
5. Clark JM, Whitney RR, George RJ, et al. Amphotericin B lipid complex: efficacy in systemic Candida infections in mice [abstract no 316]. In: Program and Abstracts of the 28th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 1988:165.
6. Whitney RR, Kunselman L, Clark JM, Bonner DP. Efficacy of amphotericin B lipid complex (ABLC) in cryptococcal meningitis in normal or immunocompromised mice [abstract no 166]. In: Program and Abstracts of the 29th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 1989:128.
7. Lopez-Berestein G, Fainstein V, Hopfer R, et al. Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study. J Infect Dis 1985;151:704-10.
8. Lopez-Berestein G, Bodey GP, Fainstein V, et al. Treatment of systemic fungal infections with liposomal amphotericin B. Arch Intern Med 1989;149:2533-6.
9. Coker RJ, Viviani M, Gazzard BG, et al. Treatment of cryptococcosis with liposomal amphotericin B (AmBisome) in 23 patients with AIDS. AIDS 1993;7:829-35.
10. Schürmann D, de Matos Marques B, Grünewald T, Pohle HD, Hahn H, Ruf B. Safety and efficacy of liposomal amphotericin B in treating AIDS-associated disseminated cryptococcosis [letter]. J Infect Dis 1991;164:620-2.
11. Graybill JR, Sharkey PK, Vincent D, et al. Amphotericin B lipid complex (ABLC) in treatment (Rx) of cryptococcal meningitis (CM) in patients with AIDS [abstract no 289]. In: Program and Abstracts of the 31st Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 1991:147.
12. Saag MS, Powderly WG, Cloud GA, et al. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. N Engl J Med 1992;326:83-9.
13. Larsen RA, Leal MAE, Chan LS. Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS: a randomized trial. Ann Intern Med 1990;113:183-7.
14. Tökés ZA, St. Péteri AK, Todd JA. Availability of liposome content to the nervous system: liposomes and the blood-brain barrier. Brain Res 1980;188:282-6.